Orlando Magic Daily on MSN
Tristan da Silva hopes time allows his shoulder and game to recover
Tristan da Silva is slated to return to the court for the Orlando Magic on Friday. He hopes that some time on the bench will ...
During his remarks at the White House today, President Trump scrambled to explain why costs aren't going down. Trump blamed Democrats, stating, "They're the ones who caused the problem." Director Rob ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. If you close one eye or put a finger to your ear, there’s an ...
The LPGA handed out several awards during its annual banquet Monday night at The Ritz-Carlton in Naples, Florida. Japan’s Miyu Yamashita was presented as the Louise Suggs Rookie of the Year after the ...
LACEY, Wash. — Editor’s note: A previous version of this story included unverified allegations from a friend of the victims that the shooting was targeted and Alex had tried to align himself with a ...
An unhinged homeless man with 20 prior arrests slashed an Upper East Side church volunteer on the arm with a boxcutter — and the suspect is already back on the street, authorities said Tuesday.
LINCOLN UNIVERSITY, Pa. (WHTM) — One person was killed and multiple others were wounded at a Chester County university Saturday evening, the Chester County District Attorney confirmed early Sunday ...
Casa da Saudade Library is displaying two new exhibits honoring two notable Portuguese families. The exhibits feature artifacts discovered in the home of Dr. João Carlos da Silva Pitta's daughter. Dr.
A pair of Los Angeles mansions—one with a “pleasure suite” outfitted with a curated collection of sex toys—is hitting the market for $85 million. The seller is British music producer Alex Da Kid, 44, ...
An asteroid named 2025 PN7 will be sharing the Earth's orbit until 2083. Earth will have a visitor within its orbit for the next several decades, according to astronomers. An asteroid named 2025 PN7 ...
Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results